PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 59 filers reported holding PREVAIL THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $1,002,000 | +38.4% | 43,430 | -39.0% | 0.01% | -30.0% |
Q3 2020 | $724,000 | -9.7% | 71,139 | +32.1% | 0.01% | -23.1% |
Q2 2020 | $802,000 | +283.7% | 53,859 | +213.5% | 0.01% | +160.0% |
Q1 2020 | $209,000 | -34.5% | 17,182 | -14.7% | 0.01% | +150.0% |
Q4 2019 | $319,000 | – | 20,154 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 13,822,463 | $318,884,000 | 2.79% |
HARVEST MANAGEMENT LLC | 70,000 | $1,615,000 | 1.32% |
HARVEST MANAGEMENT LLC | 70,000 | $1,615,000 | 1.32% |
EQUITEC PROPRIETARY MARKETS, LLC | 215,300 | $4,967,000 | 1.30% |
BARDIN HILL MANAGEMENT PARTNERS LP | 206,867 | $4,773,000 | 1.00% |
Boxer Capital, LLC | 1,123,105 | $25,910,000 | 0.83% |
TIG Advisors, LLC | 709,282 | $16,363,000 | 0.82% |
Newtyn Management, LLC | 153,617 | $3,544,000 | 0.82% |
ALPINE ASSOCIATES MANAGEMENT INC. | 857,705 | $19,787,000 | 0.81% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 205,800 | $4,748,000 | 0.74% |